Skip to Content

Join the 'Psoriasis' group to help and get support from people like you.

Psoriasis News

Related terms: Erythrodermic Psoriasis, Guttate Psoriasis, Inverse Psoriasis, Palmo-plantar Psoriasis, Psoriasis vulgaris, Pustular Psoriasis

Health Tip: Manage Psoriasis

Posted 6 days ago by

-- Managing psoriasis means learning all you can about the condition, the American Academy of Dermatology says. The group suggests: Learn as much as you can about psoriasis, including how best to treat it and potential triggers to avoid. Exercise regularly, eat a healthy diet, maintain a healthy weight, and avoid smoking and drinking. Understand your risk of developing psoriatic arthritis, and alert your doctor to the first signs of joint stiffness or discomfort. Check your fingernails for signs of psoriatic arthritis, which may include separation, pitting and discoloration. Read more

Related support groups: Psoriasis

FDA Approves Amjevita (adalimumab-atto), a Biosimilar to Humira

Posted 26 Sep 2016 by

September 23, 2016 – The U.S. Food and Drug Administration today approved Amjevita (adalimumab-atto) as a biosimilar to Humira (adalimumab) for multiple inflammatory diseases. Amjevita is approved for the following indications in adult patients: moderately to severely active rheumatoid arthritis; active psoriatic arthritis; active ankylosing spondylitis (an arthritis that affects the spine); moderately to severely active Crohn’s disease; moderately to severely active ulcerative colitis; and moderate to severe plaque psoriasis. Amjevita is also indicated for moderately to severely active polyarticular juvenile idiopathic arthritis in patients four years of age and older. Health care professionals should review the prescribing information in the labeling for detailed information about the approved uses. “This is the fourth FDA-approved biosimilar. The biosimilar pathway is still a new fr ... Read more

Related support groups: Rheumatoid Arthritis, Psoriasis, Humira, Crohn's Disease, Ulcerative Colitis, Psoriatic Arthritis, Ankylosing Spondylitis, Crohn's Disease - Maintenance, Plaque Psoriasis, Ulcerative Colitis - Maintenance, Adalimumab, Amjevita

Generic Biologic Drugs Seem as Effective as Originals

Posted 1 Aug 2016 by

MONDAY, Aug. 1, 2016 – Generic biologic drugs are similarly effective to brand-name counterparts in treating rheumatoid arthritis, inflammatory bowel disease and psoriasis, a new study says. Biologics are medications made from living cells. They are complicated to manufacturer and companies that make brand-name versions say cheaper generic versions aren't interchangeable with their products. The patents of many brand-name biologics are expiring and the use of generic versions (called biosimilars) could save patients and the healthcare system significant amounts of money, the Johns Hopkins University researchers noted. "The billion-dollar question has been whether these 'generic biologics' are the same as the brand-name versions," study leader Dr. G. Caleb Alexander, said in a university news release. "The same debate occurred with the advent of less complicated generic drugs and now ... Read more

Related support groups: Rheumatoid Arthritis, Psoriasis, Inflammatory Bowel Disease

Treating Psoriasis May Reduce Risk for Other Ills

Posted 29 Jul 2016 by

FRIDAY, July 29, 2016 – Treating the skin disease psoriasis might reduce your risk for other health problems as well, a dermatology expert says. About 7.5 million people in the United States have the chronic skin disease. The inflammatory effects of psoriasis can affect the entire body, said Dr. Jashin Wu, director of dermatology research at Kaiser Permanente Los Angeles Medical Center. "People with psoriasis, particularly those with more severe disease, have an increased risk for a variety of other health problems, including obesity, diabetes, high blood pressure, high cholesterol, stroke and heart attack," he said in an American Academy of Dermatology news release. Psoriasis is characterized by red, raised patches of skin, or plaques, covered with silvery-white scales. It's also marked by itching, burning or soreness of the skin. It is not contagious. "Psoriasis patients, even those ... Read more

Related support groups: High Blood Pressure, Diabetes, Type 2, Obesity, Hypertension, High Cholesterol, Heart Attack, Psoriasis, Inflammatory Conditions, Insulin Resistance, Pre-Diabetes, Myocardial Infarction, Plaque Psoriasis, Diabetes Mellitus, Abnormal Glucose Tolerance, Myocardial Infarction - Prophylaxis, Psoriatic Arthropathy

Health Tip: Coping With Scalp Psoriasis

Posted 24 Jun 2016 by

-- If dry, itchy scalp psoriasis is bothering you, there are things you can do to help bring it under control. The American Academy of Dermatology advises: Avoid scratching your scalp. Treat the psoriasis to minimize the itching. Be gentle when shampooing your hair; don't rub or scrub. Gently remove scales from the scalp, taking care not to pick them off. Talk to your dermatologist about a skin softener. Find healthy ways to manage stress. Read more

Related support groups: Psoriasis, Plaque Psoriasis

New Psoriasis Drug Works Longer Term, Too

Posted 8 Jun 2016 by

WEDNESDAY, June 8, 2016 – A new drug that has shown "unprecedented" effects on the skin condition psoriasis seems to work well in the longer term, too, researchers report. The drug, called ixekizumab (Taltz), was approved in March by the U.S. Food and Drug Administration. That came after initial trials showed that over 12 weeks, the drug soundly beat standard medication for moderate-to-severe psoriasis. The new findings show the benefits are still there after 60 weeks. At that point, about 80 percent of patients were seeing at least a 75 percent improvement in their skin symptoms, the researchers said. So far, ixekizumab has shown "unprecedented efficacy" against more severe cases of psoriasis, said Dr. Joel Gelfand, a dermatologist who wasn't involved in the research. The drug, given by injection, targets an inflammatory protein called IL-17, said Gelfand, who directs the Psoriasis ... Read more

Related support groups: Psoriasis, Plaque Psoriasis, Taltz, Psoriatic Arthropathy

Psoriasis Tied to Obesity, Type 2 Diabetes

Posted 27 Apr 2016 by

WEDNESDAY, April 27, 2016 – The chronic skin disease psoriasis may be linked to excess weight and type 2 diabetes, results of a new study suggest. Danish researchers found that people with type 2 diabetes had more than 50 percent greater odds of having psoriasis compared to people without diabetes. The study also found that the rate of psoriasis went up with increasing weight. For example, obese people with a body mass index (BMI) over 35 had almost double the odds of psoriasis than normal weight people did. BMI is a body fat measurement based on height and weight. A BMI of 30 or over is considered obese. Exactly how these conditions might be connected isn't clear, but the study authors suggested that genetics, smoking, drinking alcohol, or inflammation might play a role. "Psoriasis is a complex disorder," said lead researcher Dr. Ann Sophie Lonnberg, of the University of Copenhagen. ... Read more

Related support groups: Diabetes, Type 2, Obesity, Psoriasis, Plaque Psoriasis, Psoriatic Arthropathy

Psoriasis May Raise Risk for Aneurysms in Abdomen: Study

Posted 15 Apr 2016 by

THURSDAY, April 14, 2016 – Psoriasis patients may face a higher risk of an abdominal aortic aneurysm, though the overall odds of experiencing this potentially deadly blood vessel rupture are small, new research shows. The Danish scientists also found that the more severe the psoriasis – a chronic autoimmune condition characterized by scaly, red patches of skin – the more likely a person will develop an abdominal aortic aneurysm. They believe the two conditions share overlapping inflammatory processes in the body. "The association between [abdominal aortic aneurysm] and psoriasis has not been examined before, but we are not surprised by seeing a heightened risk in our study," said lead researcher Dr. Usman Khalid, a fellow in the department of cardiology at Herlev and Gentofte Hospital in Hellerup, Denmark. "Our results add to the evidence that there is an increased risk of various ... Read more

Related support groups: Psoriasis, Plaque Psoriasis, Aortic Aneurysm

Inflectra Approved as 'Biosimilar' to Remicade

Posted 7 Apr 2016 by

WEDNESDAY, April 6, 2016 – The U.S. Food and Drug Administration has approved its second-ever "biosimilar" drug, Inflectra, for adults with Crohn's disease, rheumatoid arthritis or chronic plaque psoriasis, among other prescribed uses. In a media release, the agency said Inflectra was biosimilar to Janssen Biotech's Remicade (infliximab), first licensed in 1998. A biosimilar drug is sanctioned based on its maker's ability to show that it is "highly similar" to an already-approved biological drug that is generally derived from a living organism, such as a person, animal, microorganism or yeast, the FDA said. The maker of a biosimilar drug also must prove that the product has no "clinically meaningful difference" in safety and effectiveness from the original drug, and that the newer product has only "minor differences in clinically inactive components" from the original. Inflectra's most ... Read more

Related support groups: Rheumatoid Arthritis, Psoriasis, Crohn's Disease, Remicade, Ulcerative Colitis, Psoriatic Arthritis, Ankylosing Spondylitis, Crohn's Disease - Maintenance, Ulcerative Colitis - Active, Plaque Psoriasis, Crohn's Disease - Acute, Ulcerative Colitis - Maintenance, Infliximab, Inflectra

FDA Approves Inflectra (infliximab-dyyb) a Biosimilar to Remicade

Posted 7 Apr 2016 by

April 5, 2016 – The U.S. Food and Drug Administration today approved Inflectra (infliximab-dyyb) for multiple indications. Inflectra is administered by intravenous infusion. This is the second biosimilar approved by the FDA. Inflectra is biosimilar to Janssen Biotech, Inc.’s Remicade (infliximab), which was originally licensed in 1998. Inflectra is approved and can be prescribed by a health care professional for the treatment of: adult patients and pediatric patients (ages six years and older) with moderately to severely active Crohn’s disease who have had an inadequate response to conventional therapy; adult patients with moderately to severely active ulcerative colitis who have had an inadequate response to conventional therapy; patients with moderately to severely active rheumatoid arthritis in combination with methotrexate; patients with active ankylosing spondylitis (arthritis of ... Read more

Related support groups: Rheumatoid Arthritis, Psoriasis, Crohn's Disease, Remicade, Ulcerative Colitis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Infliximab, Inflectra

FDA Approves Taltz (ixekizumab) for Plaque Psoriasis

Posted 23 Mar 2016 by

March 22, 2016 – The U.S. Food and Drug Administration today approved Taltz (ixekizumab) to treat adults with moderate-to-severe plaque psoriasis. Psoriasis is a skin condition that causes patches of skin redness and flaking. Psoriasis is an autoimmune disorder that occurs more commonly in patients with a family history of the disease, and most often begins in people between the ages of 15 and 35. The most common form of psoriasis is plaque psoriasis, in which patients develop thick, red skin with flaky, silver-white scales. “Today’s approval provides patients suffering from plaque psoriasis with another important treatment option to help relieve the skin irritation and discomfort from the condition,” said Julie Beitz, M.D., director of the Office of Drug Evaluation III in the FDA’s Center for Drug Evaluation and Research. Taltz’s active ingredient is an antibody (ixekizumab) that bi ... Read more

Related support groups: Psoriasis, Plaque Psoriasis, Taltz, Ixekizumab

Safe Treatments Available for Expectant Moms' Skin Conditions

Posted 4 Mar 2016 by

FRIDAY, March 4, 2016 – There are a number of safe and effective ways to treat chronic skin conditions in pregnant women, a dermatologist says. "If there is a way to manage your skin condition without medication during pregnancy, that is the preferred option," said Dr. Jenny Eileen Murase, an assistant clinical professor of dermatology at the University of California, San Francisco. "If you have a condition that does require medication, however, a board-certified dermatologist can help you identify a treatment that's safe for both you and your baby," she added in an American Academy of Dermatology news release. The release was timed to coincide with the academy's annual meeting, which starts Friday in Washington, D.C. Eczema is the most common rash dermatologists see in pregnancy, Murase said. "Expectant mothers often see their existing eczema get worse or have a flare for the first ... Read more

Related support groups: Clindamycin, Psoriasis, Eczema, Retin-A, Epiduo, Benzoyl Peroxide, Acne Treatment, Plaque Psoriasis, Cleocin, Adapalene, Salicylic Acid, Differin, Finacea, Aczone, Compound W, Benzaclin, Duac, Duofilm, Atralin, Adapalene/Benzoyl Peroxide

Promius Pharma Receives FDA Approval for Sernivo (betamethasone dipropionate) Spray

Posted 10 Feb 2016 by

HYDERABAD, India & PRINCETON, N.J., February 07, 2016 --(BUSINESS WIRE)--Dr. Reddy’s announced today that its US subsidiary, Promius Pharma, LLC, U.S. (BSE: 500124, NSE: DRREDDY, NYSE: RDY), has received approval for Sernivo (betamethasone dipropionate) Spray, 0.05% from the U.S. Food and Drug Administration (FDA). Sernivo Spray, a prescription topical steroid, is indicated for the treatment of mild to moderate plaque psoriasis in patients 18 years of age or older. The commercial launch of the product is planned for the coming quarter. Commenting on the approval, G V Prasad, Co-Chairman and CEO, Dr. Reddy’s Laboratories said, “The FDA approval of Sernivo Spray is a significant milestone for Promius, as it validates our committed efforts and resources to developing differentiated dermatology products from concept to commercial launch. We are delighted to receive a first round FDA appro ... Read more

Related support groups: Psoriasis, Plaque Psoriasis, Sernivo

Novartis Receives FDA Approval for Cosentyx (secukinumab) to Treat Patients with Ankylosing Spondylitis and Psoriatic Arthritis

Posted 17 Jan 2016 by

EAST HANOVER, N.J., Jan. 15, 2016 Novartis announced today that the US Food and Drug Administration (FDA) has approved Cosentyx (secukinumab) for two new indications - the treatment of adult patients with active ankylosing spondylitis (AS) and active psoriatic arthritis (PsA). AS and PsA are both life-long, painful and debilitating inflammatory diseases that affect the joints and/or spine. If not treated effectively, both conditions can lead to irreversible joint and/or spinal bone damage caused by years of inflammation.2,3,4 With these new approvals, Cosentyx is now the first and only interleukin-17A (IL-17A) antagonist approved for AS, as well as moderate to severe plaque psoriasis and PsA, which impacts as many as 30% of patients with psoriasis.5 Cosentyx was approved for adult patients with moderate to severe plaque psoriasis in January 2015 and more than 13,000 patients with this ... Read more

Related support groups: Psoriasis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Cosentyx, Secukinumab

New Drug for Severe Form of Arthritis Shows Promise in Trial

Posted 24 Dec 2015 by

WEDNESDAY, Dec. 23, 2015 – A drug recently approved for the skin condition psoriasis may also help people with a debilitating form of arthritis that attacks the spine, a new clinical trial finds. The condition, called ankylosing spondylitis, causes inflammation around the vertebrae, which can lead to chronic pain and stiffness in the back and neck – and, in some people, eventually cause some vertebrae to fuse into an immobile position. In the new trial, researchers found that a drug called secukinumab (Cosentyx) helped control symptoms in 61 percent of spondylitis patients who were given the highest dose. Experts said the results, published Dec. 24 in the New England Journal of Medicine, could open up a new option for managing spondylitis. And new options are needed, said Dr. Scott Zashin, a fellow with the American College of Rheumatology who was not involved in the study. ... Read more

Related support groups: Psoriasis, Ankylosing Spondylitis, Plaque Psoriasis, Cosentyx, Psoriatic Arthropathy

Page 1 2 3 4 5 6 Next

Ask a Question

Further Information

Related Condition Support Groups

Plaque Psoriasis, Psoriatic Arthropathy, Dermatological Disorders

Related Drug Support Groups

prednisone, methotrexate, Humira, methylprednisolone, Remicade, dexamethasone, triamcinolone, clobetasol, Therapeutic, view more... fluocinonide, Clobex, cyclosporine, desonide, Stelara, Psoriasin, hydroxyurea, Kenalog, desoximetasone, Elocon, Soriatane, Topicort, Dovonex, Tazorac, Lidex, Cordran, Halog, infliximab, Olux, Cloderm, Neoral, coal tar, Acthar, Cordran Tape, Cortizone-10, Taclonex, Kenalog-10, Vanos, feverfew, adalimumab, Acth, Locoid, halobetasol, Eczema Cream, Analpram-HC, Kenalog-40, Synalar, Deltasone, Acthar Gel, HP, Olux-E, etanercept, tazarotene, calcipotriene, Temovate, acitretin, Dermovate, Cortaid, hydrocortisone / pramoxine, Halog-E, Proctofoam HC, Verdeso, Vectical, halcinonide, anthralin, Nutracort, Hytone, Ultravate, Enstilar, Anucort-HC, methoxsalen, Locoid Lipocream, Gengraf, resorcinol, Psoriatec, Dermatop, Cyclocort, X-Seb T Plus, Dritho-Scalp, Proctosol-HC, Aristospan, Aclovate, Topicort LP, Amevive, Corticaine, ustekinumab, Cortizone-10 Plus, Drithocreme, alclometasone, Sterapred DS, Liquid Pred, Desonate, Neutrogena T / Derm, diflorasone, Hycort, Aristocort A, Neutrogena T / Gel, Oxsoralen-Ultra, Dermarest Dricort, Sterapred, Methotrexate LPF Sodium, Encort, clocortolone, Capex, Pandel, Triderm, Cortaid Maximum Strength, Cortane, DesOwen, Anti-Dandruff, Taclonex Scalp, Fototar, Aquanil HC, Pramosone, Inflectra, DHS Tar Shampoo, Coal Tar Strong, Proctozone HC, Aristocort R, Trexall, Cortizone-5, Scalp-Aid, Cort-Dome, Genasone / Aloe, Scalp-Cort, Beta HC, Instacort 10, Ivocort, Nupercainal HC 1%, Dermarest Plus Anti-Itch, Proctocream-HC, Caldecort, Lacticare-HC, Cotacort, Ala-Scalp HP, Hemorrhoidal HC, Anurx-HC, Anutone-HC, Penecort, Anuprep-HC, Anumed-HC, Hemril-HC Uniserts, Rectasol-HC, Hydrocort cream, Ala-Cort, Cortaid with Aloe, Acticort 100, Hi-Cor, Gly-Cort, Nogenic HC, Recort Plus, Rederm, Procto-Kit 2.5%, Dermolate, Aloe Cort, Cortizone for Kids, Corticreme, Delcort, Dermol HC, Sarnol-HC, Zithranol-RR, Pediaderm TA, Anthrascalp, Pediaderm HC, Trianex, Carb-O-Lac5, Carb-O-Lac HP, Anthraforte, HC Pram, Halonate, Ala-Scalp, Pramosone E, Sorilux, Calcitrene, Carmol HC, Keratol HC, MG217 Psoriasis, Halac, Tarsum, Procto-Med HC, Amjevita, Psoriatar, Clodan, Dermotic, Synalar Ointment, Zithranol, Synalar TS, Otrexup, Rasuvo, Proctocort, Derma-Smoothe / FS (Scalp), Gynecort Maximum Strength, NuZon, Procto-Pak 1%, Soriatane CK, Z-Xtra, Itch-X Lotion, Cortaid Intensive Therapy, U-Cort, Anuzone HC, Dermtex HC, Hemril-30, Proctozone-H, Proctosert HC, Olux / Olux-E Kit, OraMagic Rx, Scalacort, Fluocinonide-E, Hydrocortisone 1% In Absorbase, Analpram E, Cormax Scalp, MD Hydrocortisone, Scytera, Ultravate PAC, Temovate E, PC Tar, Dermagesic, Resinol, Neutrogena T-Scalp, Pentrax, Micanol, Anthra-Derm, A-Fil, Tegison, Cormax, Temovate Emollient, Clinacort, Prednicot, 8-MOP, Scalpicin, Folex PFS, Meticorten, Prednicen-M, Orasone, Embeline E, Clobevate, Flurosyn, Synemol, FS Shampoo, Synalar-HP, Dermacin, Licon, Fluonid, ApexiCon E, Florone, Delonide, Psorcon, Florone E, Psorcon E, Instacort, ProctoCare-HC, etretinate, efalizumab, flurandrenolide, prednicarbate, benzocaine / pyrilamine / zinc oxide, trioxsalen, corticotropin, coal tar / salicylic acid / sulfur, amcinonide, alefacept, ammonium lactate / urea, betamethasone / calcipotriene, coal tar / salicylic acid, ammonium lactate / halobetasol, Embeline, Raptiva, Maxiflor, Derma-Smoothe / FS, Lidex-E, Epifoam, Cordran SP, Apexicon, LoKara, Medotar, MG217 Medicated Tar, Doak Tar, Ionil T, Tridesilon, Fluex, Triacet, Carbo-Dome, Alphosyl 2 in 1, Doak Oil Forte, Apha Keri Tar, Linotar, Orion Coal Tar, Alphosyl, Clinitar, Reme-T, Elta Tar, Exorex, Polytar Mild, Psoriderm, Apha Keri Tar Gel, Linotar Gel 2, Cetacort, Cort-Dome High Potency, Dermacort, Westcort, Texacort, Aeroseb-HC, Ultralytic, Ultralytic 2, Pinetarsol Tar, Linotar Gel 3, R A Acne, Dovobet, Utralytic, Cutar, Doctar, Zone-A Forte, Enzone, Rectocort HC, Novacort, HC Pramoxine, Hydropram, Zone-A, Cinolar, Delta-Tritex, Aricin, Flutex, Rx Triamcinolone, Cinalog, Zetar, G-TAR, Doak Tar Oil, Oxipor VHC, Pentrax Gold, Tegrin Medicated Soap, Polytar, Psorigel, Theraplex T, Betatar Gel, Ionil T Plus, Zeprime Tar Emulsion, Tegrin Medicated, Estar, Balnetar, Procto-Kit 1%